<ruby id="ezjf9"></ruby>
<li id="ezjf9"></li><nav id="ezjf9"><center id="ezjf9"></center></nav>

    <strong id="ezjf9"></strong>
    <tbody id="ezjf9"></tbody>

      <span id="ezjf9"></span>
      <span id="ezjf9"></span>
        <em id="ezjf9"></em>

        <button id="ezjf9"><object id="ezjf9"><input id="ezjf9"></input></object></button>
        1. <tbody id="ezjf9"><pre id="ezjf9"></pre></tbody>
          
          
          <dd id="ezjf9"></dd>
          <dd id="ezjf9"></dd>

          <nav id="ezjf9"></nav>

                1. Agreement on IVD Technologies Could Help Unify IVD Standards
                  Author:Yestar      Time:2016-01-05

                  OUTSOURCING NEWS

                  ?

                  ?

                  Two European companies have agreed to cross-license their in vitro diagnostic (IVD) technologies. Epigenomics (Frankfurt) has obtained worldwide nonexclusive rights to DxS's (Manchester, UK) proprietary technology for use in research kits, and possibly in cancer IVD kits.


                  The DxS technology is known as Scorpion. It consists of a system of highly sensitive, sequence-specific molecules that contain polymerase chain reaction (PCR) primers, which are covalently linked to a probe. The probes can be used for quantitative, real-time PCR analysis, according to DxS CEO Stephen Little.


                  In return, DxS gets license and options to certain Epigenomics intellectual property covering the use of Scorpion technology for DNA methylation applications. Methylation is the process by which enzymes catalyze heavy metals into methyl groups. The process is thought to play a role in cell differentiation. Diagnosticians can measure methylation to study cancer.


                  The two companies hope that their agreement will move beyond simple exchange and enable them to influence industry more effectively.


                  “Through this strategic technology cross-licensing, [we've taken] an important step towards establishing a unified industry standard for DNA methylation detection,” says Kurt Berlin, CEO of Epigenomics.

                  0

                  Copyright ? 2017 Yestar Healthcare Holdings Company Limited     Powered By : Yestarcorp    滬ICP備10207132號-5

                    滬公網安備 31011202004160號
                  最近更新中文字幕免费 少妇高潮惨叫喷水正在播放| 真实国产乱子伦对白视频| 一本大道在线无码一区| 国产一区二区制服丝袜| 美女被黑人巨大进入的视频| 天天摸天天摸天天天天看| 高潮到不停喷水的免费视频| 精品国精品国产自在久国产| 俄罗斯14一18处交a片| 尤物tv国产精品看片在线| 亚洲欧洲中文日韩乱码av|